LXRX · Healthcare · $833M
$1.88-0.27%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
3/'26
12/'25 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출은 전년 동기 2,890만 달러에서 이번 분기 70만 달러로 급감했고, 직전 분기 2,100만 달러에서도 크게 꺾였어요.”
In the company's words · 2026 2분기 earnings call